Insights
Updating results
Showing results 1 - 24 of 25 Results per page:
No results found.
Explore our Insights
May 4, 2021
Federal Court of Appeal Affirms Minister’s Decision that CSP Eligibility Requires Claim for Active Ingredients and Excludes Formulations Claims
›
March 24, 2021
Nearly 400-Year-Old English Statute of Monopolies Not Applicable to Damage Claim Under Canada’s Patented Drug Regime
›
February 22, 2021
Federal Court Dismisses Limitation Period Defence in Patent Infringement Action under Section 8.2 of the PM(NOC) Regulations
›
Subscribe to our newsletter
December 9, 2020
Federal Court of Appeal Clarifies that a “Direct Impact” is Required to Obtain Leave to Appeal Interlocutory Orders in PM(NOC) Actions
›
August 1, 2019
Balancing Efficiency and Compressed Timelines: Two Years into the Amended Patented Medicines (Notice of Compliance) Regulations
›
August 23, 2018
Advantages Making the Federal Court of Canada an Increasingly Desirable Forum for Intellectual Property Disputes
›
August 22, 2018
HERCEPTIN Patents Survive Preliminary Non-Infringement Challenge in the First Motion Under Section 6.08 of the Patented Medicines (Notice of Compliance) Regulations
›
August 10, 2018
Did You Unintentionally Just Settle? A Cautionary Reminder to be Objectively Clear in Your Negotiations
›
June 12, 2018
Market Share Used to Establish Sales a Patentee “Could and Would” Have Made but for Infringement: Grenke v DNOW Canada ULC
›
April 4, 2018
Motion to Vary Confidentiality Restrictions in PM(NOC) Case Can Only be Brought After Action is Commenced
›
March 29, 2018
Collett v. Northland – “Retribution and Denunciation” for Egregious Infringement that Raises Questions On the Scope of Copyright and Moral Rights
›
Loading...
Showing results 1 - 24 of 25 Results per page:
No results found.